{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T08:59:18Z","timestamp":1790326758382,"version":"4.1.0"},"reference-count":83,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004846","name":"Beijing University of Chinese Medicine","doi-asserted-by":"publisher","award":["90020165120003"],"award-info":[{"award-number":["90020165120003"]}],"id":[{"id":"10.13039\/501100004846","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004846","name":"Beijing University of Chinese Medicine","doi-asserted-by":"publisher","award":["2024-JYB-KYPT-002"],"award-info":[{"award-number":["2024-JYB-KYPT-002"]}],"id":[{"id":"10.13039\/501100004846","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004846","name":"Beijing University of Chinese Medicine","doi-asserted-by":"publisher","award":["90010963420018"],"award-info":[{"award-number":["90010963420018"]}],"id":[{"id":"10.13039\/501100004846","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Sleep Medicine"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.sleep.2025.108708","type":"journal-article","created":{"date-parts":[[2025,12,6]],"date-time":"2025-12-06T16:12:16Z","timestamp":1765037536000},"page":"108708","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Sodium-glucose transporter 2 inhibitor for obstructive sleep apnea in patients with type 2 diabetes mellitus: A systematic review and meta-analysis"],"prefix":"10.1016","volume":"138","author":[{"given":"Ruifeng","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiangfan","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lili","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingling","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tonghua","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.sleep.2025.108708_bib1","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1001\/jama.2020.3514","article-title":"Diagnosis and management of obstructive sleep apnea: a review","volume":"323","author":"Gottlieb","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.sleep.2025.108708_bib2","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1056\/NEJMcp1816152","article-title":"Obstructive sleep apnea in adults","volume":"380","author":"Veasey","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.sleep.2025.108708_bib3","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/S0140-6736(13)60734-5","article-title":"Adult obstructive sleep apnoea","volume":"383","author":"Jordan","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.sleep.2025.108708_bib4","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/S2213-2600(19)30198-5","article-title":"Estimation of the global prevalence and burden of obstructive sleep apnoea: a literature-based analysis","volume":"7","author":"Benjafield","year":"2019","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.sleep.2025.108708_bib5","doi-asserted-by":"crossref","DOI":"10.1111\/jsr.12770","article-title":"Prevalence and association analysis of obstructive sleep apnea with gender and age differences - results of SHIP-Trend","volume":"28","author":"Fietze","year":"2019","journal-title":"J Sleep Res"},{"key":"10.1016\/j.sleep.2025.108708_bib6","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/S2213-2600(15)00043-0","article-title":"Prevalence of sleep-disordered breathing in the general population: the HypnoLaus study","volume":"3","author":"Heinzer","year":"2015","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.sleep.2025.108708_bib7","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.sleep.2009.10.005","article-title":"Obstructive sleep apnea syndrome in the Sao Paulo Epidemiologic Sleep Study","volume":"11","author":"Tufik","year":"2010","journal-title":"Sleep Med"},{"key":"10.1016\/j.sleep.2025.108708_bib8","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.2337\/dc08-1776","article-title":"Obstructive sleep apnea among obese patients with type 2 diabetes","volume":"32","author":"Foster","year":"2009","journal-title":"Diabetes Care"},{"key":"10.1016\/j.sleep.2025.108708_bib9","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1016\/j.amjmed.2009.04.026","article-title":"Obstructive sleep apnea as a risk factor for type 2 diabetes","volume":"122","author":"Botros","year":"2009","journal-title":"Am J Med"},{"key":"10.1016\/j.sleep.2025.108708_bib10","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1164\/rccm.201312-2209OC","article-title":"Obstructive sleep apnea and incident diabetes. A historical cohort study","volume":"190","author":"Kendzerska","year":"2014","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.sleep.2025.108708_bib11","doi-asserted-by":"crossref","first-page":"3015","DOI":"10.1001\/jama.284.23.3015","article-title":"Longitudinal study of moderate weight change and sleep-disordered breathing","volume":"284","author":"Peppard","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/j.sleep.2025.108708_bib12","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1164\/rccm.200504-637OC","article-title":"Association of sleep apnea and type II diabetes: a population-based study","volume":"172","author":"Reichmuth","year":"2005","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.sleep.2025.108708_bib13","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/S2213-2600(13)70039-0","article-title":"Obstructive sleep apnoea and type 2 diabetes mellitus: a bidirectional association","volume":"1","author":"Aurora","year":"2013","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.sleep.2025.108708_bib14","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.4187\/respcare.10551322","article-title":"Sleep-disordered breathing and cardiovascular disorders","volume":"55","author":"Budhiraja","year":"2010","journal-title":"Respir Care"},{"key":"10.1016\/j.sleep.2025.108708_bib15","doi-asserted-by":"crossref","first-page":"ITC81","DOI":"10.7326\/AITC201912030","article-title":"Obstructive sleep apnea","volume":"171","author":"Patel","year":"2019","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.sleep.2025.108708_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.smrv.2023.101809","article-title":"Pharmacotherapy for obstructive sleep apnea - a systematic review and meta-analysis of randomized controlled trials","volume":"70","author":"Lee","year":"2023","journal-title":"Sleep Med Rev"},{"key":"10.1016\/j.sleep.2025.108708_bib17","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1136\/thx.56.7.513","article-title":"Partners of patients with sleep apnoea\/hypopnoea syndrome: effect of CPAP treatment on sleep quality and quality of life","volume":"56","author":"McArdle","year":"2001","journal-title":"Thorax"},{"key":"10.1016\/j.sleep.2025.108708_bib18","article-title":"Positional therapy for obstructive sleep apnoea","volume":"5","author":"Srijithesh","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.sleep.2025.108708_bib19","doi-asserted-by":"crossref","first-page":"335","DOI":"10.5664\/jcsm.7640","article-title":"Treatment of adult obstructive sleep apnea with positive airway pressure: an American academy of Sleep Medicine Clinical Practice Guideline","volume":"15","author":"Patil","year":"2019","journal-title":"J Clin Sleep Med"},{"key":"10.1016\/j.sleep.2025.108708_bib20","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.smrv.2004.01.002","article-title":"Health care costs and the sleep apnea syndrome","volume":"8","author":"Wittmann","year":"2004","journal-title":"Sleep Med Rev"},{"key":"10.1016\/j.sleep.2025.108708_bib21","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1513\/AnnalsATS.202101-060OC","article-title":"Effect of continuous positive airway pressure on weight and local adiposity in adults with obstructive sleep apnea: a meta-analysis","volume":"18","author":"Chen","year":"2021","journal-title":"Ann Am Thorac Soc"},{"key":"10.1016\/j.sleep.2025.108708_bib22","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1038\/s41581-024-00836-y","article-title":"Applications of SGLT2 inhibitors beyond glycaemic control","volume":"20","author":"O'Hara","year":"2024","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.sleep.2025.108708_bib23","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1038\/s41574-020-0392-2","article-title":"Sodium-glucose cotransporter type 2 inhibitors for the treatment of type 2 diabetes mellitus","volume":"16","author":"Scheen","year":"2020","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.sleep.2025.108708_bib24","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1002\/ejhf.2172","article-title":"Sodium-glucose co-transporter 2 inhibitors: strength of evidence for a cardio-renal-metabolic therapy","volume":"23","author":"Parcha","year":"2021","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.sleep.2025.108708_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.endmts.2021.100084","article-title":"SGLT2 inhibitors and sleep apnea; how helpful are the medications: a meta-analysis","volume":"2","author":"Mir","year":"2021","journal-title":"Endocrine and Metabolic Science"},{"key":"10.1016\/j.sleep.2025.108708_bib26","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/S0735-1097(25)01009-5","article-title":"Evaluating the efficacy OF sodium glucose COTRANSPORTOR-2 (SGLT-2) \u0130NHIBITORS IN management OF obstructive sleep apnea; a SYSTEMIC review and meta-analysis","volume":"85","author":"Akram","year":"2025","journal-title":"JACC (J Am Coll Cardiol)"},{"key":"10.1016\/j.sleep.2025.108708_bib27","doi-asserted-by":"crossref","DOI":"10.1111\/jsr.70196","article-title":"Evaluating the efficacy of sodium glucose Cotransporter-2 inhibitors in management of obstructive sleep apnea; a systematic review and meta-analysis","author":"Murtaza","year":"2025","journal-title":"J Sleep Res"},{"key":"10.1016\/j.sleep.2025.108708_bib28","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.sleep.2025.108708_bib29","doi-asserted-by":"crossref","first-page":"479","DOI":"10.5664\/jcsm.6506","article-title":"Clinical practice guideline for diagnostic testing for adult obstructive sleep apnea: an American Academy of Sleep Medicine clinical practice guideline","volume":"13","author":"Kapur","year":"2017","journal-title":"J Clin Sleep Med"},{"key":"10.1016\/j.sleep.2025.108708_bib30","doi-asserted-by":"crossref","first-page":"S8","DOI":"10.2337\/dc15-S005","article-title":"2. Classification and diagnosis of diabetes","volume":"38","year":"2015","journal-title":"Diabetes Care"},{"key":"10.1016\/j.sleep.2025.108708_bib31","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"key":"10.1016\/j.sleep.2025.108708_bib32","article-title":"ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions","volume":"355","author":"Sterne","year":"2016","journal-title":"BMJ"},{"key":"10.1016\/j.sleep.2025.108708_bib33","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1186\/1471-2288-14-135","article-title":"Estimating the sample mean and standard deviation from the sample size, median, range and\/or interquartile range","volume":"14","author":"Wan","year":"2014","journal-title":"BMC Med Res Methodol"},{"key":"10.1016\/j.sleep.2025.108708_bib34","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1177\/0962280216669183","article-title":"Optimally estimating the sample mean from the sample size, median, mid-range, and\/or mid-quartile range","volume":"27","author":"Luo","year":"2016","journal-title":"Stat Methods Med Res"},{"key":"10.1016\/j.sleep.2025.108708_bib35","doi-asserted-by":"crossref","DOI":"10.1002\/9780470712184","author":"Higgins","year":"2008","journal-title":"Cochrane handbook for systematic reviews of interventions"},{"key":"10.1016\/j.sleep.2025.108708_bib36","doi-asserted-by":"crossref","first-page":"3007","DOI":"10.2337\/dc20-1096","article-title":"The impact of empagliflozin on obstructive sleep apnea and cardiovascular and renal Outcomes: an Exploratory Analysis of the EMPA-REG OUTCOME trial","volume":"43","author":"Neeland","year":"2020","journal-title":"Diabetes Care"},{"key":"10.1016\/j.sleep.2025.108708_bib37","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1007\/s11325-022-02594-2","article-title":"Ertugliflozin and incident obstructive sleep apnea: an analysis from the VERTIS CV trial","volume":"27","author":"Wojeck","year":"2023","journal-title":"Schlaf & Atmung [Sleep & breathing]"},{"key":"10.1016\/j.sleep.2025.108708_bib38","first-page":"118","article-title":"Efficacy of Canagliflozin and Metformin in type 2 diabetes mellitus combined with mild obstructive sleep apnea syndrome","volume":"20","author":"Yang","year":"2023","journal-title":"CHINA MEDICAL HERALD"},{"key":"10.1016\/j.sleep.2025.108708_bib39","doi-asserted-by":"crossref","first-page":"497","DOI":"10.14740\/jocmr4626","article-title":"Effect of treatment with sodium-glucose cotransporter 2 inhibitor on the initiation of continuous positive airway pressure therapy in type 2 diabetic patients with obstructive sleep apnea syndrome","volume":"13","author":"Kusunoki","year":"2021","journal-title":"J Clin Med Res"},{"key":"10.1016\/j.sleep.2025.108708_bib40","first-page":"154","article-title":"The clinical effect of dapagliflozin combined with metformin in the treatment of type 2 diabetes mellitus patients with obstructive sleep apnea syndrome","volume":"15","author":"Zhou","year":"2018","journal-title":"Practical Journal of Clinical Medicine"},{"key":"10.1016\/j.sleep.2025.108708_bib41","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1038\/s41387-019-0098-5","article-title":"Effect of dapagliflozin on obstructive sleep apnea in patients with type 2 diabetes: a preliminary study","volume":"9","author":"Tang","year":"2019","journal-title":"Nutr Diabetes"},{"key":"10.1016\/j.sleep.2025.108708_bib42","article-title":"Effect of sodium glucose cotransporter 2 inhibitor on sleep apnea in chronic heart failure patients with type 2 diabetes mellitus","volume":"203","author":"Ishiwata","year":"2021","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.sleep.2025.108708_bib43","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1038\/s41440-024-01982-3","article-title":"Tofogliflozin reduces sleep apnea severity in patients with type 2 diabetes mellitus and heart failure: a prospective study","volume":"48","author":"Ishiwata","year":"2025","journal-title":"Hypertens Res"},{"key":"10.1016\/j.sleep.2025.108708_bib44","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1507\/endocrj.EJ17-0440","article-title":"Effect of sodium glucose cotransporter 2 inhibitors on obstructive sleep apnea in patients with type 2 diabetes","volume":"65","author":"Sawada","year":"2018","journal-title":"Endocr J"},{"key":"10.1016\/j.sleep.2025.108708_bib45","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1111\/1753-0407.12452","article-title":"HbA1c levels are associated with severity of hypoxemia and not with apnea hypopnea index in patients with type 2 diabetes: results from a cross-sectional study","volume":"9","author":"Rusu","year":"2017","journal-title":"J Diabetes"},{"key":"10.1016\/j.sleep.2025.108708_bib46","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1007\/s11325-019-01967-4","article-title":"Chronic intermittent hypoxia in obstructive sleep apnea: a narrative review from pathophysiological pathways to a precision clinical approach","volume":"24","author":"Labarca","year":"2020","journal-title":"Sleep Breath"},{"key":"10.1016\/j.sleep.2025.108708_bib47","doi-asserted-by":"crossref","first-page":"937","DOI":"10.3390\/biomedicines12050937","article-title":"Effect of SGLT2-Inhibitors on polygraphic parameters in elderly patients affected by heart failure, type 2 diabetes mellitus, and sleep apnea","volume":"12","author":"Armentaro","year":"2024","journal-title":"Biomedicines"},{"key":"10.1016\/j.sleep.2025.108708_bib48","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.3390\/biomedicines13061474","article-title":"Effects of SGLT2 inhibitors on sleep apnea parameters and cheyne-stokes respiration in patients with acute decompensated heart failure: a prospective cohort Study","volume":"13","author":"Kalaydzhiev","year":"2025","journal-title":"Biomedicines"},{"key":"10.1016\/j.sleep.2025.108708_bib49","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1186\/s12967-025-06312-w","article-title":"Unveiling the benefits of Vitamin D3 with SGLT-2 inhibitors for hypertensive obese obstructive sleep apnea patients","volume":"23","author":"Loh","year":"2025","journal-title":"J Transl Med"},{"key":"10.1016\/j.sleep.2025.108708_bib50","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1007\/s00228-024-03643-3","article-title":"DAHOS Study: efficacy of dapagliflozin in treating heart failure with reduced ejection fraction and obstructive sleep apnea syndrome\u2014A 3-month, multicenter, randomized controlled clinical trial","volume":"80","author":"Xie","year":"2024","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.sleep.2025.108708_bib51","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1507\/endocrj.EJ17-0545","article-title":"The effectiveness of dapagliflozin for sleep-disordered breathing among Japanese patients with obesity and type 2 diabetes mellitus","volume":"65","author":"Furukawa","year":"2018","journal-title":"Endocr J"},{"key":"10.1016\/j.sleep.2025.108708_bib52","doi-asserted-by":"crossref","DOI":"10.1016\/j.smrv.2021.101473","article-title":"New frontiers in pharmacologic obstructive sleep apnea treatment: a narrative review","volume":"57","author":"Sch\u00fctz","year":"2021","journal-title":"Sleep Med Rev"},{"key":"10.1016\/j.sleep.2025.108708_bib53","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.bbrc.2006.03.015","article-title":"Chronic intermittent hypoxia activates nuclear factor-kappaB in cardiovascular tissues in vivo","volume":"343","author":"Greenberg","year":"2006","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.sleep.2025.108708_bib54","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1152\/jappl.1992.72.5.1978","article-title":"Carotid chemoreceptors, systemic blood pressure, and chronic episodic hypoxia mimicking sleep apnea","volume":"72","author":"Fletcher","year":"1992","journal-title":"J Appl Physiol"},{"key":"10.1016\/j.sleep.2025.108708_bib55","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1152\/japplphysiol.00994.2005","article-title":"Chronic intermittent hypoxia alters NE reactivity and mechanics of skeletal muscle resistance arteries","volume":"100","author":"Phillips","year":"2006","journal-title":"J Appl Physiol"},{"key":"10.1016\/j.sleep.2025.108708_bib56","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1113\/jphysiol.2003.048173","article-title":"Intermittent hypoxia increases insulin resistance in genetically obese mice","volume":"552","author":"Polotsky","year":"2003","journal-title":"J Physiol"},{"key":"10.1016\/j.sleep.2025.108708_bib57","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.smrv.2019.04.009","article-title":"Efficacy of pharmacotherapy for OSA in adults: a systematic review and network meta-analysis","volume":"46","author":"Gaisl","year":"2019","journal-title":"Sleep Med Rev"},{"key":"10.1016\/j.sleep.2025.108708_bib58","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1038\/s41569-020-0406-8","article-title":"SGLT2 inhibitors: mechanisms of cardiovascular benefit beyond glycaemic control","volume":"17","author":"Cowie","year":"2020","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.sleep.2025.108708_bib59","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.2215\/CJN.10391012","article-title":"Proximal tubule function and response to acidosis","volume":"9","author":"Curthoys","year":"2014","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.sleep.2025.108708_bib60","doi-asserted-by":"crossref","first-page":"6039","DOI":"10.3390\/ijms24076039","article-title":"Unlocking the full potential of SGLT2 inhibitors: expanding applications beyond glycemic control","volume":"24","author":"Youssef","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.sleep.2025.108708_bib61","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1161\/CIRCULATIONAHA.116.021887","article-title":"Sodium glucose cotransporter 2 inhibitors in the treatment of diabetes mellitus: cardiovascular and kidney effects, potential mechanisms, and clinical applications","volume":"134","author":"Heerspink","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.sleep.2025.108708_bib62","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.cmet.2017.04.011","article-title":"Sodium-Glucose Co-transporters and their inhibition: clinical physiology","volume":"26","author":"Ferrannini","year":"2017","journal-title":"Cell Metab"},{"key":"10.1016\/j.sleep.2025.108708_bib63","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21217833","article-title":"Molecular mechanisms of SGLT2 inhibitor on cardiorenal protection","volume":"21","author":"Hou","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.sleep.2025.108708_bib64","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1111\/dom.13126","article-title":"Why do SGLT2 inhibitors reduce heart failure hospitalization? A differential volume regulation hypothesis","volume":"20","author":"Hallow","year":"2018","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.sleep.2025.108708_bib65","doi-asserted-by":"crossref","first-page":"421","DOI":"10.3389\/fendo.2018.00421","article-title":"The effects of sodium-glucose cotransporter 2 inhibitors on sympathetic nervous activity","volume":"9","author":"Wan","year":"2018","journal-title":"Front Endocrinol"},{"key":"10.1016\/j.sleep.2025.108708_bib66","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1056\/NEJMoa1504720","article-title":"Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes","volume":"373","author":"Zinman","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.sleep.2025.108708_bib67","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1056\/NEJMoa1811744","article-title":"Canagliflozin and renal outcomes in type 2 diabetes and nephropathy","volume":"380","author":"Perkovic","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.sleep.2025.108708_bib68","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1056\/NEJMoa2022190","article-title":"Cardiovascular and renal outcomes with empagliflozin in heart failure","volume":"383","author":"Packer","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.sleep.2025.108708_bib69","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1161\/CIRCULATIONAHA.120.048740","article-title":"Blood pressure effects of Canagliflozin and clinical outcomes in type 2 diabetes and chronic kidney disease: insights from the CREDENCE trial","volume":"143","author":"Ye","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.sleep.2025.108708_bib70","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1172\/JCI118235","article-title":"Sympathetic neural mechanisms in obstructive sleep apnea","volume":"96","author":"Somers","year":"1995","journal-title":"J Clin Investig"},{"key":"10.1016\/j.sleep.2025.108708_bib71","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s11325-022-02606-1","article-title":"Potential use of SGLT-2 inhibitors in obstructive sleep apnea: a new treatment on the horizon","volume":"27","author":"Tanriover","year":"2023","journal-title":"Sleep Breath"},{"key":"10.1016\/j.sleep.2025.108708_bib72","doi-asserted-by":"crossref","first-page":"3169","DOI":"10.2337\/dc13-0387","article-title":"Characterization of renal glucose reabsorption in response to dapagliflozin in healthy subjects and subjects with type 2 diabetes","volume":"36","author":"DeFronzo","year":"2013","journal-title":"Diabetes Care"},{"key":"10.1016\/j.sleep.2025.108708_bib73","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.ebiom.2017.05.028","article-title":"SGLT2 inhibition by empagliflozin promotes fat utilization and browning and attenuates inflammation and insulin resistance by polarizing M2 macrophages in diet-induced Obese mice","volume":"20","author":"Xu","year":"2017","journal-title":"EBioMedicine"},{"key":"10.1016\/j.sleep.2025.108708_bib74","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/s40268-016-0137-9","article-title":"Changes in levels of biomarkers associated with adipocyte function and insulin and Glucagon Kinetics during treatment with dapagliflozin among Obese type 2 diabetes mellitus patients","volume":"16","author":"Okamoto","year":"2016","journal-title":"Drugs R&D"},{"key":"10.1016\/j.sleep.2025.108708_bib75","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1111\/dom.12459","article-title":"Long-term glycaemic response and tolerability of dapagliflozin versus a sulphonylurea as add-on therapy to metformin in patients with type 2 diabetes: 4-year data","volume":"17","author":"Del Prato","year":"2015","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.sleep.2025.108708_bib76","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1002\/oby.23331","article-title":"SGLT inhibitors on weight and body mass: a meta-analysis of 116 randomized-controlled trials","volume":"30","author":"Cheong","year":"2022","journal-title":"Obesity"},{"key":"10.1016\/j.sleep.2025.108708_bib77","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1002\/oby.22066","article-title":"The Association between the dosage of SGLT2 inhibitor and weight reduction in type 2 diabetes patients: a meta-analysis","volume":"26","author":"Cai","year":"2018","journal-title":"Obesity"},{"key":"10.1016\/j.sleep.2025.108708_bib78","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1111\/dom.14234","article-title":"Empagliflozin treatment effects across categories of baseline HbA1c, body weight and blood pressure as an add-on to metformin in patients with type 2 diabetes","volume":"23","author":"Inzucchi","year":"2021","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.sleep.2025.108708_bib79","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/S0140-6736(13)60683-2","article-title":"Efficacy and safety of canagliflozin versus glimepiride in patients with type 2 diabetes inadequately controlled with metformin (CANTATA-SU): 52 week results from a randomised, double-blind, phase 3 non-inferiority trial","volume":"382","author":"Cefalu","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.sleep.2025.108708_bib80","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/S2213-8587(14)70120-2","article-title":"Comparison of empagliflozin and glimepiride as add-on to metformin in patients with type 2 diabetes: a 104-week randomised, active-controlled, double-blind, phase 3 trial","volume":"2","author":"Ridderstr\u00e5le","year":"2014","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.sleep.2025.108708_bib81","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0279889","article-title":"Effect of SGLT-2 inhibitors on body composition in patients with type 2 diabetes mellitus: a meta-analysis of randomized controlled trials","volume":"17","author":"Pan","year":"2022","journal-title":"PLoS One"},{"key":"10.1016\/j.sleep.2025.108708_bib82","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1164\/rccm.200807-1076OC","article-title":"Relationship between overnight rostral fluid shift and Obstructive Sleep Apnea in nonobese men","volume":"179","author":"Redolfi","year":"2009","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.sleep.2025.108708_bib83","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.1007\/s00125-022-05773-8","article-title":"SGLT2 inhibitors in type 2 diabetes: a systematic review and meta-anal ysis of cardiovascular outcome trials balancing their risks and benefits","volume":"65","author":"Marilly","year":"2022","journal-title":"Diabetologia"}],"container-title":["Sleep Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1389945725023834?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1389945725023834?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T05:58:18Z","timestamp":1773899898000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1389945725023834"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":83,"alternative-id":["S1389945725023834"],"URL":"https:\/\/doi.org\/10.1016\/j.sleep.2025.108708","relation":{},"ISSN":["1389-9457"],"issn-type":[{"value":"1389-9457","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sodium-glucose transporter 2 inhibitor for obstructive sleep apnea in patients with type 2 diabetes mellitus: A systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Sleep Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.sleep.2025.108708","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"108708"}}